ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael E. Halkos
Faraz Kerendi
Joel S. Corvera
Robert A. Guyton
Jakob Vinten-Johansen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halkos, M. E.
Right arrow Articles by Zhao, Z.-Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halkos, M. E.
Right arrow Articles by Zhao, Z.-Q.
Related Collections
Right arrow Myocardial protection
Right arrowRelated Article

Ann Thorac Surg 2004;78:961-969
© 2004 The Society of Thoracic Surgeons


Original Article: cardiovascular

Myocardial protection with postconditioning is not enhanced by ischemic preconditioning

Michael E. Halkos, MDa, Faraz Kerendi, MDa, Joel S. Corvera, MDa, Ning-Ping Wang, MDa, Hajime Kin, MDa, Christopher S. Payne, BSa, He-Ying Sun, PhDa, Robert A. Guyton, MDa, Jakob Vinten-Johansen, PhDa, Zhi-Qing Zhao, PhDa,*

a Cardiothoracic Research Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Crawford Long Hospital, Emory University School of Medicine, Atlanta, Georgia, USA

Accepted for publication March 8, 2004.

* Address reprint requests to Dr Zhao, Cardiothoracic Research Laboratory, Crawford Long Hospital, Emory University School of Medicine, 550 Peachtree St, NE, Atlanta, GA 30308-2225, USA
zzhao{at}emory.edu


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
BACKGROUND: Ischemic preconditioning (IPC) has been used in off-pump coronary artery bypass surgery (OPCAB) to reduce potential injury secondary to ligation of the target vessel. Previous studies have shown that a brief period of repetitive coronary occlusion applied at the onset of reperfusion, postconditioning (postcon), attenuates myocardial injury. This study tested the hypothesis that coincident application of IPC and postcon would provide more cardioprotection than either intervention alone by inhibiting oxidant-mediated injury after ischemia and reperfusion.

METHODS: Four groups of open-chest canines endured 60 minutes coronary occlusion followed by 3 hours reperfusion: control (n = 10), no intervention; IPC (n = 9), 5 minutes left anterior descending coronary artery occlusion preceded 10 minutes of reperfusion before prolonged occlusion; postcon (n = 10), 3 cycles of 30 seconds reperfusion-30 seconds reocclusion were imposed immediately upon reperfusion; IPC+postcon (n = 8), IPC and postcon algorithms were combined.

RESULTS: Collateral blood flow during ischemia was similar in all groups. Compared to control (24% ± 2%), infarct size was comparably reduced in IPC (13% ± 2%* [* denotes p less than 0.05 compared with control]), and postcon (10% ± 1%*), consistent with a reduction in plasma creative kinase activity in these groups; infarct size was not further reduced by IPC+postcon (12% ± 3%*). Tissue water content in ischemic myocardium was comparably reduced in IPC, postcon, and IPC+postcon compared to control. Superoxide anion generation detected by dihydroethidium staining in area at risk myocardium was comparably reduced in all intervention groups relative to control. Plasma malondialdehyde (µM), a lipid peroxidation byproduct of oxidant injury, was less at 1 hour of reperfusion in IPC (2.2 ± 0.2*), postcon (2.1 ± 0.2*), and IPC+postcon (2.5 ± 0.2*) relative to control (3.3 ± 0.2). Ventricular fibrillation occurred less often in all intervention groups.

CONCLUSIONS: No additive cardioprotective effects by IPC and postcon were observed in a canine model of regional ischemia and reperfusion. The potent attenuation of myocardial injury by postcon may suggest a clinically applicable strategy during some surgical revascularization procedures (ie, OPCAB).


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Although early restoration of myocardial blood flow after coronary artery occlusion with percutaneous coronary interventions or coronary artery bypass surgery is critical to the salvage of ischemic myocardium, an increasing number of studies indicate that reperfusion also elicits an inflammatory response that contributes to postischemic injury. This reperfusion injury could ostensibly offset the benefits of myocardial revascularization. It has been suggested that the manifestations of reperfusion injury are initiated during the early minutes of reperfusion, and are exacerbated as reperfusion continues [1, 2]. Furthermore, modifying the conditions and composition of the reperfusate during early reperfusion has been an effective strategy to attenuate postischemic injury after surgical revascularization using cardiopulmonary bypass and cardioplegia [3, 4]. However, cardioplegia is not an option in off-pump coronary artery bypass surgery (OPCAB). Hence, cardioprotective strategies are limited in this case. Ischemic preconditioning (IPC) of the myocardium served by target vessels has been applied during off-pump procedures with limited benefit [5], although IPC is purportedly one of the most potent forms of cardioprotection in the laboratory setting.

Perfusion-assisted direct coronary artery bypass surgery (PADCAB) strategies have been reported to improve postreperfusion outcomes [6, 7]. However, PADCAB requires delivery devices for perfusion of vessel conduits, therefore increasing the complexity of the procedure. We have recently shown that postconditioning (postcon), a brief period of repetitive coronary artery occlusion and reperfusion applied at the onset of reperfusion, significantly reduced infarct size, preserved endothelial function, and inhibited inflammatory and endothelial cell-cell interactions [8]. Postconditioning has been reproduced in independent laboratories [9] and in cell culture systems [10]. These data demonstrate a novel endogenous cardioprotective mechanism that can be applied to OPCAB procedures in which brief periods of ischemia are introduced during reperfusion.

Both preconditioning and postconditioning have demonstrated powerful cardioprotection in the laboratory setting. However, preconditioning and postconditioning intervene at opposite ends of the ischemic event. The present study tested the hypothesis that coapplication of ischemic preconditioning and postconditioning in a canine model of regional ischemia and reperfusion would provide additive protection compared to either intervention alone.


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Surgical preparation
The experimental procedures were conducted in compliance with the "Guiding Principles in the Use and Care of Animals" published by the National Institutes of Health (National Institutes of Health publication No. 85 to 23, revised 1996) and were approved by The Institutional Animal Care and Use Committee of Emory University.

Adult canines weighing 25 to 35 kg were premedicated with an intramuscular injection of morphine sulfate (4 mg/kg) followed by continuous inhalation of isoflurane (1%) after endotracheal intubation. Exposure of the left anterior descending artery and instrumentation for measuring left ventricular pressure and regional contractile function was achieved, as reported previously [8]. A catheter was inserted into the left atrium for injection of neutron-activated microspheres (BioPal Laboratories, Worcester, MA) to measure regional myocardial blood flow. All dogs were systemically heparinized with 300 U/kg sodium heparin before starting the experiment.

Experimental protocol
In all animals, the left anterior descending coronary artery (LAD) was reversibly occluded by gently pulling up on an occluding silk ligature for 60 minutes followed by 3 hours of reperfusion. The animals were randomly assigned to 1 of 4 groups (Fig 1): (1) control (n = 10), no intervention before ischemia or reperfusion; (2) IPC (n = 9), the LAD was occluded for 5 minutes followed by 10 minutes reperfusion before 60 minutes occlusion; (3) postcon (n = 10), after 60 minutes LAD occlusion, reperfusion was initiated for 30 seconds followed by 30 seconds of reocclusion, repeated for 3 cycles (3 minutes total intervention); (4) IPC+postcon (n = 8), the above IPC and postcon protocols were combined. After ligature release, the ischemic myocardium was reperfused for a total of 3 hours in all groups, inclusive of postcon interventions. At the end of reperfusion, the heart was excised to evaluate infarct size, tissue edema, regional myocardial blood flow, and superoxide anion generation in the area at risk.



View larger version (17K):
[in this window]
[in a new window]
 
Fig 1. Experimental protocol used to determine the effect of ischemic preconditioning (IPC, postconditioning (Postcon, or IPC+Postcon on myocardium after ischemia (I = dark box) and reperfusion (R = open box). Control group (n = 10); IPC (n = 9) elicited by 5 minutes ischemia followed by 10 minutes reperfusion before index ischemia; Postcon (n = 10) performed by 3 cycles of 30 seconds reperfusion followed by 30 seconds ischemia; and IPC+Postcon (n = 8) performed by combining both protocols.

 
Hemodynamics and regional contractile function
Hemodynamic data were acquired during a 12 second period of respiratory apnea, using an analog-to-digital converter and acquisition software (Spectrum, Wake Forest University, Wake Forest, IL). Heart rate, mean aortic pressure, left ventricular systolic pressure, and left ventricular end-diastolic pressure were determined at baseline, at 60 minutes ischemia, and after 1, 2, and 3 hours of reperfusion. A pair of 5 MHz ultrasonic crystals was implanted in the midmyocardium of the area at risk (AR), and connected to a sonomicrometer (Model 120, Triton Technology, Inc, San Diego, CA) to measure regional contractile function as expressed as percent systolic shortening and segmentwork (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Hemodynamics and Regional Contractile Function During Experiment

 
Determination of area at risk and infarct size
After harvesting the heart, the LAD was religated in the original position, and diluted Unisperse blue dye was injected into the aortic root to stain the nonischemic region blue and thereby outline the AR. The left ventricle was then cut into transverse slices, and the AR was separated from the nonischemic zone and incubated in a 1% solution of triphenyltetrazolium chloride (TTC) at 37°C to differentiate the area of necrosis from the nonnecrotic AR. The AR, as a percent of the left ventricular mass (AR/LV), and the area of necrosis (AN), as a percent of the AR (AN/AR), were calculated by tissue weight, as reported previously [8].

Regional myocardial blood flow
Regional myocardial blood flow in the subepicardial and subendocardial regions of the AR and nonischemic LV free wall was determined by neutron-activated microspheres at baseline, ischemia, and at 15 minutes and 3 hours of reperfusion using the reference sampling method as previously described [8]. Results are expressed as mL/min/g tissue.

Determination of plasma creatine kinase (CK) and malondialdehyde (MDA)
Arterial blood samples were withdrawn at baseline, at the end of ischemia, and at 1, 2, and 3 hours of reperfusion to measure CK activity (Sigma Diagnostic, St. Louis, MO), an index of morphologic injury, and MDA (lipid peroxidation assay, Calbiochem, San Diego, CA), an index of lipid peroxidation reflecting oxygen free radical mediated membrane damage [11, 12]. Plasma CK and MDA were analyzed spectrophotometrically (SPECTRAmax, Molecular Devices, Sunnyvale, CA) at 340 nm and 586 nm absorbance, respectively. Creatine kinase activity was expressed as U/g protein, and plasma MDA values were given as µM.

Tissue edema in area at risk myocardium
Tissue samples (0.3 g) were taken from subepicardial and subendocardial regions of the area at risk, and from the contralateral nonischemic left ventricular free wall, quickly blotted of surface moisture, and weighed. The samples were desiccated in an 80°C oven for 48 hours and reweighed. Tissue water content was calculated as 100*[1-(dry weight/wet weight)].

In situ detection of superoxide anion generation in myocardium
Ischemic and nonischemic myocardium was stained with dihydroethidium (DHE, Molecular Probes, Eugene, OR) to identify superoxide anions, as previously described [8]. Dihydroethidium reacts with superoxide anions to form ethidium (Eth) bromide, which in turn intercalates into DNA to provide nuclear fluorescence as a marker of superoxide anion generation. Briefly, transmural tissue samples from nonischemic and ischemic myocardium were harvested at the end of the experiment, placed in cold saline, and embedded in optimal cutting temperature (OCT) compound for cryosectioning. The tissue sections (20 µm) were cut using a Hacker-Bright cryostat, thaw-mounted on Fisher-Plus (Fisher Scientific) slides, and stained with 10 µmol/L DHE at 37°C for 30 minutes. The image of ethidium staining, as well as a quantitative assessment of fluorescent intensity was obtained using an imaging system (Image-Pro Plus, Media Cybemetics, Silver Spring, MD) with a 585 nm long-pass filter. Generation of superoxide anions in tissue after 3 hours of reperfusion, demonstrated by red fluorescent labeling, represents the phase of sustained production of reactive oxygen species (ROS) after the initial reperfusion burst [13, 14]. The enhanced Eth-DNA fluorescence is an indicator of superoxide generation within cells [15]. The fluorescent intensity of the cells was expressed as arbitrary units of per millimeter square field.

Ventricular fibrillation
The incidence of ventricular fibrillation (VF) was recorded in all experiments. Ventricular fibrillation did not occur during ischemia in any of the animals. If VF occurred upon reperfusion, the heart was quickly defibrillated. Ventricular fibrillation was deemed intractable if sinus rhythm could not be restored with 2 countershocks or if hemodynamic instability resulted in cardiac arrest. Although animals with intractable VF and/or cardiac arrest were excluded from the final analysis, the occurrence of all VF in animals requiring defibrillation was documented and compared in all groups.

Statistical analysis
A one-way analysis of variance (ANOVA) followed by Student-Newman-Keuls test was used to analyze group differences in a single point data such as infarct size and tissue water content. Hemodynamic data and other time-dependent determinations were analyzed by repeated measures ANOVA followed by posthoc analysis with Student-Newman-Keuls multiple comparisons. A {chi}2 analysis was used to test differences in the incidence of VF. A p value less than 0.05 was considered significant. Results are reported as mean ± standard error of the mean.


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Forty-eight dogs were initially entered into the study. Four dogs were excluded due to a small area at risk and high transmural blood flow (>0.2 mL/min/g) during ischemia as quantified by microspheres. Seven other experiments were excluded due to intractable VF and/or cardiac arrest, although these data were recorded to detect differences in reperfusion arrhythmias. Data from 37 dogs are included in the final analysis: 10 control (con), 9 IPC, 10 postcon, and 8 IPC+postcon. Data from ten dogs (4 con, 4 IPC, 2 postcon), previously reported [8] and following an identical protocol for the respective groups, were randomly selected from the previous study for inclusion in the present study.

Hemodynamics and regional contractile function
Baseline function was similar in all groups (Table 1). In all groups, LAD occlusion caused paradoxical bulging in the area at risk. Contractile dysfunction in the area at risk, quantified as percent systolic shortening and segment work, persisted during the 3 hours of reperfusion without any significant return of regional function, and with no statistically significant group differences.

Regional myocardial blood flow
Regional myocardial blood flow was equivalent in the nonischemic myocardium at baseline in all groups studied, and remained unchanged during the experiment. The LAD occlusion reduced regional myocardial blood flow in the AR subepicardium and subendocardium (data not shown) comparably in all groups by approximately 94% (Fig 2). Release of the coronary ligature resulted in a marked increase in subepicardial regional myocardial blood flow in the AR at 15 minutes of reperfusion that was significantly less in IPC, postcon, and IPC+postcon compared to control (p = 0.04, Fig 2). There were no significant differences in subendocardial flow during ischemia among the four groups (control 0.05 ± 0.02, IPC 0.04 ± 0.01, postcon 0.05 ± 0.01, and IPC+postcon 0.02 ± 0.01 [mL/min/g of tissue]), suggesting that changes in infarct size were independent of collateral flow. Similarly, there were no significant group differences in subendocardial blood flow during any of the other time points during reperfusion.



View larger version (13K):
[in this window]
[in a new window]
 
Fig 2. Line graph showing the time course of subepicardial blood flow determined by neutron-activated microspheres. Base, Isch, R15, and R180 represent baseline, ischemia, 15, and 180 minutes of reperfusion, respectively. * p less than 0.05. Values expressed as mean ± standard error of the mean. • = control; {diamondsuit} = ischemic preconditioning (IPC); {square} = postcon; {triangleup} = IPC+postcon.

 
Area at risk and infarct size
The AR/LV was similar among all groups as shown in Figure 3. The IPC reduced infarct size (AN/AR) by approximately 50% relative to the control group. Postcon reduced infarct size to the same extent as IPC. Despite comparable cardioprotection of the individual strategies, however, there was no significant additive effect when IPC and postcon were combined. Subendocardial blood flow was plotted against the size of the infarction to exclude collateral blood flow as a determinant of infarct size. There was an inverse relationship between infarct size and collateral blood flow. However, there was a downward shift in the regression lines in the IPC, postcon, and IPC+postcon groups compared to the control group (Fig 4), suggesting that the infarct size reduction in the three intervention groups was independent of collateral blood flow during coronary occlusion.



View larger version (18K):
[in this window]
[in a new window]
 
Fig 3. Bar graph showing area at risk (AR) relative to left ventricular (LV) mass (AR/LV) and area of necrosis (AN) relative to AR. Infarct size (AN/AR) was significantly smaller in postconditioning (postcon), ischemic preconditioning (IPC), and IPC+postcon versus control but no significant differences were found among the three intervention groups. *p less than 0.05 versus control. All values expressed as mean ± standard error of the mean. {square} = control; {blacksquare} = IPC, {cjs2113} = postcon; {cjs2117} = IPC+postcon.

 


View larger version (14K):
[in this window]
[in a new window]
 
Fig 4. The relationship between infarct size (AN/AR) and collateral blood flow measured in subendocardial AR during 60 minutes of ischemia. There was an inverse relationship between the infarct size and collateral blood flow in each group; therefore infarct size reduction was independent of collateral blood flow. Each symbol represents one case. • with dotted line = control; {diamond} with solid line = ischemic preconditioning (IPC); {square} with dashed/dotted line = postconditioning (postcon); {blacktriangleup} with long dashed line = IPC+postcon. (AN = area of necrosis; AR = area at risk.)

 
Plasma CK activity
Creatine kinase activity increased only slightly during ischemia and showed a gradual rise during the 3 hours of reperfusion (Table 2). At the end of 3 hours of reperfusion, CK levels were significantly lower in the IPC (10 ± 1.3) and postcon (9.0 ± 1.2) groups (p = 0.04) compared to the control group (14 ± 1.4) but there was no significant difference observed in the IPC+postcon group (13 ± 3.3) relative to control.


View this table:
[in this window]
[in a new window]
 
Table 2. Plasma Creatine Kinase Activity During Course of Experiment

 
Tissue edema in ischemic myocardium
Tissue water content in the nonischemic myocardium was comparable among all groups and was significantly greater in the AR compared to the nonischemic zone (Fig 5). . Tissue water content was significantly greater in the subepicardial regions in the control (82.2 ± 0.37) compared to IPC (79.0 ± 0.27), postcon (78.5 ± 0.38), and IPC+postcon (80.8 ± 0.49). However, tissue water content was comparably increased in all groups in the subendocardial regions.



View larger version (38K):
[in this window]
[in a new window]
 
Fig 5. Bar graph showing myocardial tissue water content (%) after ischemia and reperfusion. Normal: nonischemic (Non-isch) zone; AAR Epi: ischemic epicardium; AAR Endo: ischemic endocardium. Ischemic epicardial tissue water content was significantly less in ischemic preconditioning (IPC), postconditioning (postcon), and IPC+postcon compared with control. *p less than 0.05 versus control. Data expressed as mean ± standard error of the mean. {square} = control; {cjs2112} = IPC; {blacksquare} = postcon; {cjs2117} = IPC+postcon.

 
Plasma MDA during ischemia and reperfusion
Plasma MDA levels increased slightly during ischemia but without significant differences from baseline among groups. At 1 hour of reperfusion, MDA was significantly lower in IPC, postcon, and IPC+postcon compared to control, but no differences were observed between the three intervention groups (Table 3).


View this table:
[in this window]
[in a new window]
 
Table 3. Plasma MDA Levels During Course of Experiment

 
Dihydroethidium staining in the ischemic myocardium
The intensity of DHE staining in nonischemic myocardium was comparably modest among all groups. However, in the AR myocardium, fluorescent staining intensity after 3 hours of reperfusion was greater compared to the nonischemic zone, and was markedly reduced in the IPC and postcon groups. There was no apparent intensity difference in IPC+postcon relative to the IPC and postcon groups (Fig 6).



View larger version (153K):
[in this window]
[in a new window]
 
Fig 6. Fluorescence photomicrographs (magnification x200) with dihydroethidium showing in situ detection of superoxide in the ischemic myocardium after ischemia and 3 hours of reperfusion. The fluorescent intensity of endothelium and myocardium was significantly increased relative to normal tissue after ischemia and reperfusion in the control group. Ethidium nuclear staining, however, was considerably less intense in ischemic myocardium in the ischemic preconditioning (IPC), postconditioning (Postcon, and IPC+Postcon) groups compared to the control. This image is representative of at least four experiments in each group. The fluorescent intensity of the cells was expressed as arbitrary units (arb. u) of per millimeter square field. *p less than 0.01 versus normal (nor) tissue; {dagger}p less than 0.05 versus control.

 
Incidence of ventricular fibrillation upon reperfusion
Ventricular fibrillation occurred more frequently in control (50% of group) compared to IPC (25%) and postcon (18%). Furthermore, VF occurred in only 10% of IPC+postcon cases. Although differences in the occurrence of VF were noted between groups, statistical significance could not be achieved due to the small sample size and inadequate power for this variable.


    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Prolonged ischemia caused by total coronary artery occlusion followed by reperfusion induces endothelial dysfunction and inflammatory cell activation. However, even brief periods of occlusion, such as that used during OPCAB to improve visibility of the target vessel, may cause injury to the myocardium and endothelium [16]. Therefore, strategies to prevent myocardial or endothelial dysfunction and cell death from ischemia and reperfusion injuries may improve postoperative outcomes in patients following OPCAB, in which cardioplegia cannot be applied. One such strategy involves preconditioning [16–18] the myocardium served by the target vessel with brief periods of ischemia and reperfusion applied before temporary occlusion of the target vessel. Preconditioning is touted as the most potent and consistent cardioprotective strategy for regional coronary occlusion. Another strategy involves PADCAB, which can be used to control the conditions and composition (ie, addition of adenosine) of the reperfusion phase of the revascularized segment [7, 19, 20]. Interestingly, these two strategies derive similar cardioprotection, but are directed at opposite ends of the ischemic event, with ischemic preconditioning triggering preemptive adaptations of the myocardium before ischemia, while PADCAB exerts its effects by modifying the mechanisms of reperfusion. However, the benefits of preconditioning the myocardium served by the target vessel have been somewhat inconsistent [5, 21].

In the present study, we demonstrate a novel strategy that can potentially be used in OPCAB surgery to protect the revascularized segment from reperfusion injury. Postconditioning with a rapid sequence of repetitive reperfusions and reocclusions at the onset of reperfusion provides potent cardioprotection comparable to that of ischemic preconditioning. The protective effects of ischemic preconditioning and postconditioning were independent of changes in collateral blood flow in the area at risk during ischemia, which is a known determinant of infarct size after coronary occlusion [22]. The cardioprotection of postconditioning may be related to the observed inhibition of superoxide anion generation and oxidant-mediated cellular membrane damage expressed as lipid peroxidation. However, there were no additive protective effects when both preconditioning and postconditioning were sequentially applied. None of the strategies improved regional postischemic contractile function at 3 hours of reperfusion. However, there was a tendency for the combination to reduce the incidence of reperfusion ventricular fibrillation.

In this study, the generation of reactive oxygen species (ROS) during reperfusion, was comparably reduced by both ischemic preconditioning and postconditioning. Although free radical generation occurs during prolonged ischemia [23], a larger oxidative "burst" occurs with reperfusion [13, 24], which contributes to the development of postischemic injury [14, 25]. In addition, there is a sustained elevated level of ROS observed during later reperfusion [13]. In a study by Kevin and colleagues [14], ROS generation was reduced during the first 10 minutes of reperfusion in preconditioned hearts. Others have confirmed the effects of ischemic preconditioning in decreasing ROS production during reperfusion [11, 25]. In contrast to ischemic preconditioning, postconditioning can only reduce ROS generation during early reperfusion by mechanisms other than those engaged by preconditioning. Our results show similar reductions in DHE fluorescence after 3 hours of reperfusion with both preconditioning and postconditioning; lipid peroxidation products were also reduced at 1 hour of reperfusion, consistent with a reduction in ROS and ROS-derived products during the earlier stages of reperfusion. The observation by Vinten-Johansen and colleagues [26] that the cardioprotection by postconditioning is abrogated if the algorithm is delayed and the initial minutes of reperfusion are uncontrolled, is consistent with the hypothesis that postconditioning attenuates the large burst of ROS generated during the early moments of reperfusion, as well as the sustained generation during late reperfusion. However, whether postconditioning reduces ROS generation and during which time point of reperfusion this reduction takes place must still be elucidated. Although we cannot directly correlate the reduction of infarct size with the reduction of ROS in this study, a reduction of oxygen radicals is strongly associated with a reduction of postischemic injury [14, 25]. However, we cannot exclude the possibility that postconditioning reduces postischemic injury by mechanisms unrelated to ROS generation.

Several studies have documented the antiarrhythmic effects of ischemic preconditioning [27, 28]. In the present study, we found that VF occurred less often in the treatment groups compared to the control group. Ventricular fibrillation occurred in only 10% of the combined ischemic preconditioning and postconditioning cases. In addition, ventricular tachyarrhythmias that usually occurred with the initiation of reperfusion promptly resolved with reocclusion during the period of postconditioning. However, the study was not sufficiently powered to show statistical differences for this variable by nonparametric techniques, so we cannot claim attenuation of reperfusion arrhythmias as a benefit of postconditioning.

Limitations
As has been previously reported [29], both morphine sulfate and isoflurane used in the present study for premedication and anesthesia have preconditioning-mimetic effects. This may help to explain why the average infarct size in the control group was smaller than that reported by others who used different premedication and anesthesia regimens in canine models of regional ischemia-reperfusion [30]. However, the animals in all groups were premedicated and anesthetized in the same manner, and myocardial injury was significantly reduced by ischemic preconditioning and postconditioning. Therefore, we can exclude the possibility that changes in the reduction of infarct size and inhibition of ROS in the IPC and postconditioning groups were related to the anesthetic drugs used to some extent. In addition, either ischemic preconditioning or postconditioning alone may exert the maximum protection relative to the combination in our coronary occlusion model. We cannot exclude the possibility that a longer occlusion time or a more proximal LAD ligation would have unmasked additive cardioprotective effects of preconditioning and postconditioning, but a study with prolonged ischemic times should be performed. Finally, although we have implied that postconditioning could be applied during OPCAB, a model more closely resembling the surgical conditions during off-pump surgery would be needed to demonstrate protection. Furthermore, a prospective clinical trial would be required to document the safety and efficacy of this intervention in the clinical OPCAB setting.

In conclusion, the present study demonstrated the cardioprotective effects of postconditioning in the setting of acute myocardial infarction. However, the study failed to demonstrate enhanced cardioprotection when both preconditioning and postconditioning were combined. A preliminary report by Yang and colleagues [9] in a rabbit model of coronary occlusion-reperfusion suggests that preconditioning and postconditioning are additive during more prolonged ischemia than tested in the present study. Therefore, an additive effect may be expressed if coronary occlusion times exceed those used in the present study. The data from the present study suggest that the area at risk myocardium can be salvaged by manipulating the dynamics of the immediate onset of reperfusion. Even a short period of full reperfusion preceding the cyclical postconditioning algorithm can abrogate its cardioprotection [26]. Postconditioning offers a practical alternative to preconditioning in that foreknowledge of ischemia is not required. Postconditioning would be simple to apply in the OPCAB setting in which full reperfusion after completion of the distal anastomosis is preceded by cyclical interruptions of reflow according to a specific algorithm. Postconditioning may also be applied after completion of vascular grafts in surgical revascularization using cardiopulmonary bypass, or as a final procedure before release of aortic cross clamp. In addition, this procedure may also be suitable for other clinical settings such as percutaneous transluminal coronary angioplasty and organ transplantation.


    Acknowledgments
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
The authors are grateful for the technical contributions of L. Susan Schmarkey and Sara Katzmark, and for the assistance of Laurie Berley in preparing the manuscript. This work was supported, in part, by funds from the Carlyle Fraser Heart Center of Emory University School of Medicine and National Institutes of Health grants HL069487 (JV-J) and HL64886 (ZQ-Z).


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Lefer AM, Tsao PS, Lefer DJ, Ma X-L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J. 1991;5:2029–2034[Abstract]
  2. Tsao PS, Aoki N, Lefer DJ, Johnson G III, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990;82:1402–1412[Abstract/Free Full Text]
  3. Sato H, Jordan JE, Zhao Z-Q, Sarvotham SS, Vinten-Johansen J. Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. Ann Thorac Surg. 1997;64:1099–1107[Abstract/Free Full Text]
  4. Vinten-Johansen J, Lefer DJ, Nakanishi K, et al. Controlled coronary hydrodynamics at the time of reperfusion reduces postischemic injury. Coron Artery Dis. 1992;3:1081–1093
  5. Penttila HJ, Lepojarvi MVK, Kaukoranta PK, et al. Ischemic preconditioning does not improve myocardial preservation during off-pump multivessel coronary operation. Ann Thorac Surg. 2003;75:1246–1252[Abstract/Free Full Text]
  6. Guyton RA, Thourani VH, Puskas JD, et al. Perfusion-assisted direct coronary artery bypass: selective graft perfusion in off-pump cases. Ann Thorac Surg. 2000;69:171–175[Abstract/Free Full Text]
  7. Puskas JD, Vinten-Johansen J, Muraki S, Guyton RA. Myocardial protection for off-pump coronary artery bypass surgery. Thorac Cardiovasc Surg. 2001;13:82–88
  8. Zhao Z-Q, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol (Heart Circ Physiol). 2003;285:579–588
  9. Yang X-M, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by activation of ERK and production of nitric oxide. Circulation. 2003;108(Suppl):IV745
  10. Zhao Z-Q, Sun H-Y, Wang N-P, et al. Hypoxic post-conditioning reduces cardiomyocyte loss by inhibiting reactive oxygen species-triggered mitochondrial calcium overload. Circulation. 2003;108(Suppl):IV174
  11. Crestanello JA, Lingle DM, Kamelguard J, Millili J, Whitman GJ. Ischemic preconditioning decreases oxidative stress during reperfusion: a chemiluminescence study. J Surg Res. 1996;65:53–58[Medline]
  12. Tosaki A, Cordis GA, Szerdahelyi P, Engelman RM, Das DK. Effects of preconditioning on reperfusion arrhythmias myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol. 1994;23:365–373[Medline]
  13. Duilio C, Ambrosio G, Kuppusamy P, et al. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol (Heart Circ Physiol). 2001;280:H2649–H2657[Abstract/Free Full Text]
  14. Kevin LG, Camara AKS, Riess ML, Novalija E, Stowe DF. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol (Heart Circ Physiol). 2003;284:H566–H574[Abstract/Free Full Text]
  15. Vanden Hoek TL, Li C, Shao ZH, Schumacker PT, Becker LB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol. 1997;29:2571–2583[Medline]
  16. Thourani VH, Nakamura M, Duarte IG, et al. Ischemic preconditioning attenuates postischemic coronary artery endothelial dysfunction in a model of minimally invasive direct coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1999;117:383–389[Abstract/Free Full Text]
  17. Laurikka J, Wu ZK, Iisalo P, et al. Regional ischemic preconditioning enhances myocardial performance in off-pump coronary artery bypass grafting. Chest. 2002;121:1183–1189[Abstract/Free Full Text]
  18. Doi Y, Wantanabe G, Kotoh K, Ueyama K, Misaki T. Myocardial ischemic preconditioning during minimally invasive direct coronary artery bypass grafting attenuates ischemia-induced electrophysiological changes in human ventricle. Jpn J Thorac Cardiovasc Surg. 2003;51:144–150[Medline]
  19. Vassiliades TA Jr, Nielsen JL, Lonquist JL. Coronary perfusion methods during off-pump coronary artery bypass: results of a randomized clinical trial. Ann Thorac Surg. 2002;74:S1383–1389[Abstract/Free Full Text]
  20. Muraki S, Morris CD, Budde JM, et al. Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion. J Thorac Cardiovasc Surg. 2001;121:570–579[Abstract/Free Full Text]
  21. Hatori N, Segawa D, Hinokiyama K, et al. Effects of ischemic preconditioning and synchonrized coronary venous retroperfusion in an off-pump coronary artery bypass grafting model. Artif Organs. 2001;25:47–52[Medline]
  22. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardial at risk) and collateral flow. Lab Invest. 1979;40:633–644[Medline]
  23. Becker LB, Vanden Hoek TL, Shao ZH, Li CQ, Shumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol (Heart Circ Physiol). 1999;277:H2240–2246[Abstract/Free Full Text]
  24. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: an overview [Review]. Cardiovasc Drugs Ther. 1991;5(Suppl 2):249–268
  25. Vanden Hoek TL, Becker LB, Shao ZH, Li CQ, Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res. 2000;86:541–548[Abstract/Free Full Text]
  26. Vinten-Johansen J, Kin H, Sun H-Y, et al. Post-conditioning reduces myocardial injury by inhibiting reactive oxygen species during reperfusion. Circulation. 2003;108(Suppl):IV-219
  27. Wu ZK, Livainen T, Pehkonen E, Laurikka J, Tarkka MR. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization. Circulation. 2002;106:3091–3096[Abstract/Free Full Text]
  28. Airaksinen KE, Huikuri HV. Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty. J Am Coll Cardiol. 1997;29:1035–1038[Abstract]
  29. Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res. 1999;84:1396–1400[Abstract/Free Full Text]
  30. Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DC. Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology. 2000;92:1400–1407[Medline]

Related Article

Invited commentary
Robert Lasley
Ann. Thorac. Surg. 2004 78: 969. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
Y. Nishino, I. G. Webb, S. M. Davidson, A. I. Ahmed, J. E. Clark, S. Jacquet, A. M. Shah, T. Miura, D. M. Yellon, M. Avkiran, et al.
Glycogen Synthase Kinase-3 Inactivation Is Not Required for Ischemic Preconditioning or Postconditioning in the Mouse
Circ. Res., August 1, 2008; 103(3): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Ferdinandy, R. Schulz, and G. F. Baxter
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Vinten-Johansen, Z.-Q. Zhao, R. Jiang, A. J. Zatta, and G. P. Dobson
Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury
J Appl Physiol, October 1, 2007; 103(4): 1441 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Sato, R. Bolli, G. D. Rokosh, Q. Bi, S. Dai, G. Shirk, and X.-L. Tang
The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2557 - H2564.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. P. Loukogeorgakis, R. Williams, A. T. Panagiotidou, S. K. Kolvekar, A. Donald, T. J. Cole, D. M. Yellon, J. E. Deanfield, and R. J. MacAllister
Transient Limb Ischemia Induces Remote Preconditioning and Remote Postconditioning in Humans by a KATP Channel Dependent Mechanism
Circulation, September 18, 2007; 116(12): 1386 - 1395.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Gomez, H. Thibault, A. Gharib, J.-M. Dumont, G. Vuagniaux, P. Scalfaro, G. Derumeaux, and M. Ovize
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1654 - H1661.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. I. Deyhimy, N. W. Fleming, I. G. Brodkin, and H. Liu
Anesthetic Preconditioning Combined with Postconditioning Offers No Additional Benefit Over Preconditioning or Postconditioning Alone
Anesth. Analg., August 1, 2007; 105(2): 316 - 324.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Z.-X. Jin, J.-J. Zhou, M. Xin, D.-R. Peng, X.-M. Wang, S.-H. Bi, X.-F. Wei, and D.-H. Yi
Postconditioning the Human Heart with Adenosine in Heart Valve Replacement Surgery
Ann. Thorac. Surg., June 1, 2007; 83(6): 2066 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. C. Manintveld, M. te Lintel Hekkert, E. J. van den Bos, G. M. Suurenbroek, D. H. Dekkers, P. D. Verdouw, J. M. Lamers, and D. J. Duncker
Cardiac effects of postconditioning depend critically on the duration of index ischemia
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1551 - H1560.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-L. Tang, H. Sato, S. Tiwari, B. Dawn, Q. Bi, Q. Li, G. Shirk, and R. Bolli
Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2308 - H2317.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Ramzy, V. Rao, and R. D. Weisel
Clinical applicability of preconditioning and postconditioning: The cardiothoracic surgeons's view
Cardiovasc Res, May 1, 2006; 70(2): 174 - 180.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z.-Q. Zhao and J. Vinten-Johansen
Postconditioning: Reduction of reperfusion-induced injury
Cardiovasc Res, May 1, 2006; 70(2): 200 - 211.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Gateau-Roesch, L. Argaud, and M. Ovize
Mitochondrial permeability transition pore and postconditioning
Cardiovasc Res, May 1, 2006; 70(2): 264 - 273.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. A. Kloner and S. H. Rezkalla
Preconditioning, postconditioning and their application to clinical cardiology
Cardiovasc Res, May 1, 2006; 70(2): 297 - 307.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. J. Zatta, H. Kin, G. Lee, N. Wang, R. Jiang, R. Lust, J. G. Reeves, J. Mykytenko, R. A. Guyton, Z.-Q. Zhao, et al.
Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling
Cardiovasc Res, May 1, 2006; 70(2): 315 - 324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. M. Schwartz and C. J. Lagranha
Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1011 - H1018.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. P. Loukogeorgakis, A. T. Panagiotidou, D. M. Yellon, J. E. Deanfield, and R. J. MacAllister
Postconditioning Protects Against Endothelial Ischemia-Reperfusion Injury in the Human Forearm
Circulation, February 21, 2006; 113(7): 1015 - 1019.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Staat, G. Rioufol, C. Piot, Y. Cottin, T. T. Cung, I. L'Huillier, J.-F. Aupetit, E. Bonnefoy, G. Finet, X. Andre-Fouet, et al.
Postconditioning the Human Heart
Circulation, October 4, 2005; 112(14): 2143 - 2148.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. E. Darling, R. Jiang, M. Maynard, P. Whittaker, J. Vinten-Johansen, and K. Przyklenk
Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1618 - H1626.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
E. Lucchinetti, R. da Silva, T. Pasch, M. C. Schaub, and M. Zaugg
Anaesthetic preconditioning but not postconditioning prevents early activation of the deleterious cardiac remodelling programme: evidence of opposing genomic responses in cardioprotection by pre- and postconditioning
Br. J. Anaesth., August 1, 2005; 95(2): 140 - 152.
[Abstract] [Full Text] [PDF]